Skip to main content
Total Market Cap: $50,922,018,870 Volume (24h): $1,222,079,346

Cara Therapeutics Inc.

Cara Therapeutics Inc. (CARA) logo
Rank 20
About

Cara Therapeutics is a biopharmaceutical company that focuses on the development of compound-based treatments for pain, inflammation, and pruritus. Several of its products are in the preclinical stage of development, including KORSUVA, oral KORUSUVA, and CR845/CR701. While the company is based in Stamford, Connecticut, it has plans to expand into Asian markets.

Website
$8.4700
USD
2.87%
Market cap
$393,157,919
Total volume
$2,388,014
Shares outstanding
46,417,700
Rank 20
Website
About

Cara Therapeutics is a biopharmaceutical company that focuses on the development of compound-based treatments for pain, inflammation, and pruritus. Several of its products are in the preclinical stage of development, including KORSUVA, oral KORUSUVA, and CR845/CR701. While the company is based in Stamford, Connecticut, it has plans to expand into Asian markets.

Markets
Exchange Symbol Volume (24h) Volume (%) Price
Nasdaq
CARA
$2,388,014
100%
$8.4700
Chart
Social media

Share widget

Copy widget code
Subscribe to our newsletter